Literature DB >> 9877044

Lung deposition of budesonide from turbuhaler in asthmatic children.

J H Wildhaber1, S G Devadason, J M Wilson, C Roller, T Lagana, L Borgström, P N LeSouëf.   

Abstract

UNLABELLED: The aim of our study was to evaluate the effect of age on lung deposition of radiolabelled budesonide, delivered as a dry powder via Turbuhaler to asthmatic children. A group of 23 asthmatic children, aged 6 to 16 years, with relatively stable asthma inhaled 99mTc-labelled budesonide from a dry powder inhaler (Turbuhaler). Body and lung deposition was assessed using a gamma camera. The mean (range) median peak inspiratory flow during inhalation was 65 1 x min(-1) (45 to 76 1 x min(-1)). Mean (range) total lung deposition of 99mTc-labelled budesonide, expressed as a percentage of the metered dose, was 29.1% (15.6-47.2%) and was positively and significantly correlated with age, height and peak inspiratory flow.
CONCLUSION: Total lung deposition of radiolabelled budesonide from a dry powder inhaler (Turbuhaler), is age dependent in children with moderate asthma. However, lung deposition is still satisfactory, even in younger children with lower peak inspiratory flows.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877044     DOI: 10.1007/s004310050990

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Optical feedback training of inhalation with Autohaler and Turbuhaler in COPD patients.

Authors:  J Steier; T Trammer; R M Cloes; W Petro
Journal:  Lung       Date:  2003       Impact factor: 2.584

2.  Inhalation devices.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 3.  The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.

Authors:  Jeffry Weers; Andy Clark
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

4.  A pharmacokinetic simulation tool for inhaled corticosteroids.

Authors:  Benjamin Weber; Guenther Hochhaus
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

Review 5.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Clinical pharmacokinetics of inhaled budesonide.

Authors:  R Donnelly; J P Seale
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

7.  Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.

Authors:  Conor A Ruzycki; Laleh Golshahi; Reinhard Vehring; Warren H Finlay
Journal:  Pharm Res       Date:  2014-01-07       Impact factor: 4.200

Review 8.  Once-daily inhaled corticosteroids in children with asthma: dry powder inhalers.

Authors:  C Möller
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 9.  Budesonide/formoterol: a review of its use in asthma.

Authors:  David R Goldsmith; Gillian M Keating
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates.

Authors:  Andrew R Clark; Jeffry G Weers; Rajiv Dhand
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-10-31       Impact factor: 2.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.